Helen Ma

3.9k total citations · 1 hit paper
66 papers, 1.2k citations indexed

About

Helen Ma is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Helen Ma has authored 66 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 20 papers in Pathology and Forensic Medicine and 17 papers in Oncology. Recurrent topics in Helen Ma's work include Lymphoma Diagnosis and Treatment (19 papers), T-cell and Retrovirus Studies (8 papers) and Histone Deacetylase Inhibitors Research (8 papers). Helen Ma is often cited by papers focused on Lymphoma Diagnosis and Treatment (19 papers), T-cell and Retrovirus Studies (8 papers) and Histone Deacetylase Inhibitors Research (8 papers). Helen Ma collaborates with scholars based in United States, China and Hong Kong. Helen Ma's co-authors include Sarah Byford, Tim Dalgleish, Willem Kuyken, Rachel Hayes, Richard Byng, Ben Whalley, Rod S Taylor, Fiona C Warren, Susanne Schweizer and Mark Williams and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Helen Ma

60 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy of Mindfulness-Based Cognitive Therapy in Prevention of Depressive Relapse

2016 532 citations Helen Ma et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Helen Ma United States	17	458	295	291	176	128	66	1.2k
Liselotte Jansson Sweden	24	186 0.4×	332 1.1×	172 0.6×	307 1.7×	143 1.1×	39	2.1k
Hannah Jones United Kingdom	21	368 0.8×	222 0.8×	95 0.3×	109 0.6×	137 1.1×	61	1.7k
Jeffrey D. Bernhard United States	20	395 0.9×	142 0.5×	117 0.4×	156 0.9×	103 0.8×	78	2.3k
Jerald Bain Canada	26	465 1.0×	259 0.9×	66 0.2×	111 0.6×	109 0.9×	74	1.8k
Janice Thompson United States	24	325 0.7×	204 0.7×	96 0.3×	41 0.2×	324 2.5×	58	1.5k
J. Wasserman Sweden	22	255 0.6×	207 0.7×	40 0.1×	298 1.7×	121 0.9×	78	1.5k
Jonas Bybjerg‐Grauholm Denmark	21	241 0.5×	388 1.3×	97 0.3×	25 0.1×	53 0.4×	68	1.4k
Yumiko Inoue Japan	16	187 0.4×	142 0.5×	160 0.5×	50 0.3×	95 0.7×	61	965
Jerzy Wasserman Sweden	18	119 0.3×	117 0.4×	71 0.2×	227 1.3×	45 0.4×	66	1.2k
Silvia Leonor Olivera United States	18	145 0.3×	468 1.6×	29 0.1×	80 0.5×	34 0.3×	58	1.1k

Countries citing papers authored by Helen Ma

Since Specialization

Citations

This map shows the geographic impact of Helen Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Ma more than expected).

Fields of papers citing papers by Helen Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Ma. The network helps show where Helen Ma may publish in the future.

Co-authorship network of co-authors of Helen Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Ma. A scholar is included among the top collaborators of Helen Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Ma. Helen Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Teng, Xueyi, et al.. (2025). Polygenic Risk, Agent Orange Exposure, and Lymphoid Neoplasms in the Veterans Affairs Million Veteran Program. JAMA Network Open. 8(8). e2526787–e2526787.

Ma, Helen, Haichao Zhang, Andrew J. Souers, et al.. (2024). Anti-Leukemia Combinatorial Efficacy of ABBV155, a B7H3-BCL-XL Inhibitor Antibody-Drug Conjugate, in Combination with Venetoclax through BCL-XL/BIM and BCL-2/BIM Complex Dissociations. Blood. 144(Supplement 1). 2760–2760.

Ma, Helen, Susan O’Brien, & Pankaj Gupta. (2023). Treatment Patterns and Outcomes in U.S. Military Veterans Diagnosed With Chronic Lymphocytic Leukemia (CLL). Clinical Lymphoma Myeloma & Leukemia. 24(2). 77–82. 1 indexed citations

Jia, Yannan, Zhe Wang, Connie C. Weng, et al.. (2023). Co-targeting BCL-XL and BCL-2 by PROTAC 753B eliminates leukemia cells and enhances efficacy of chemotherapy by targeting senescent cells. Haematologica. 108(10). 2626–2638. 34 indexed citations

Zeng, Zhihong, Abhishek Maiti, Shelley M. Herbrich, et al.. (2022). Triple combination targeting methyltransferase, BCL‐2, and PD‐1 facilitates antileukemia responses in acute myeloid leukemia. Cancer. 129(4). 531–540. 7 indexed citations

Lue, Jennifer Kimberly, Helen Ma, Enrica Marchi, John Spivack, & Owen A. O’Connor. (2021). Peripheral T-Cell Lymphoma Involvement of the Central Nervous System: Impact of Novel Therapeutics on Clinical Outcomes. Blood. 138(Supplement 1). 2469–2469. 1 indexed citations

Sawas, Ahmed, Helen Ma, Andrei R. Shustov, et al.. (2019). Belinostat Induces High Overall Response Rate (ORR) in Patients with Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL). Blood. 134(Supplement_1). 4050–4050. 5 indexed citations

Ragon, Brittany Knick, Olatoyosi Odenike, Maria R. Baer, et al.. (2019). Oral MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Patients With Acute Myeloid Leukemia With RAS Mutations: A Phase II Study. Clinical Lymphoma Myeloma & Leukemia. 19(7). 431–440.e13. 51 indexed citations

Ma, Helen, Ardalan Davarifar, & Jennifer E. Amengual. (2018). The Future of Combination Therapies for Peripheral T Cell Lymphoma (PTCL). Current Hematologic Malignancy Reports. 13(1). 13–24. 22 indexed citations

10.

Zhou, Zhi, et al.. (2018). Smart KneeBrace for osteoarthritis patients' gait analysis: correlations of motion capture and physical function parameters, pain, self-reported questionnaires. Osteoarthritis and Cartilage. 26. S382–S383.

11.

Baran, Natalia, Shannon Sweeney, Alessia Lodi, et al.. (2017). Inhibition of Oxphos with Iacs-010759 Depletes AML Leukemia Initiating Cells (LIC) in Vitro and Improves Survival in Pre-Clinical AML Models. Blood. 130. 1350–1350. 1 indexed citations

12.

Zhang, Qi, Lina Han, Tianyu Cai, et al.. (2017). BCL-2 Antagonist ABT-199 Combined with Complex I Inhibitor IACS-010759 Blocks Mitochondrial Respiration and Facilitates Anti-Leukemia Efficacy in Pre-Clinical AML Models. Blood. 130. 1362–1362. 2 indexed citations

13.

Wong, Samuel Yeung Shan, Dexing Zhang, Benjamin Hon Kei Yip, et al.. (2017). Comparing the Effects of Mindfulness-Based Cognitive Therapy and Sleep Psycho-Education with Exercise on Chronic Insomnia: A Randomised Controlled Trial. Psychotherapy and Psychosomatics. 86(4). 241–253. 52 indexed citations

14.

Kerry, Jon, Laura Godfrey, Emmanouela Repapi, et al.. (2017). MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. Cell Reports. 18(2). 482–495. 51 indexed citations

15.

Mu, Chaofeng, Xiaoyan Wu, Helen Ma, et al.. (2016). Effective Concentration of a Multikinase Inhibitor within Bone Marrow Correlates with In Vitro Cell Killing in Therapy-Resistant Chronic Myeloid Leukemia. Molecular Cancer Therapeutics. 15(5). 899–910. 5 indexed citations

16.

Zhāng, Qí, Lina Han, Ce Shi, et al.. (2016). Upregulation of MAPK/MCL-1 Maintaining Mitochondrial Oxidative Phosphorylation Confers Acquired Resistance to BCL-2 Inhibitor Venetoclax in AML. Blood. 128(22). 101–101. 5 indexed citations

17.

Ferrari, Alessio, G. R. Hudes, Michael A. Carducci, et al.. (2016). E2809. Androgen receptor (AR) modulation by bicalutamide (Bic) and MK-2206 (MK) in prostate cancer (PC) patients (pts) with rising PSA at high risk of progression after local treatment (tx). Annals of Oncology. 27. vi249–vi249. 1 indexed citations

18.

Ip, Margaret, et al.. (2013). Increased nasopharyngeal carriage of serotypes 6A, 6C, and 6D Streptococcus pneumoniae after introduction of childhood pneumococcal vaccination in Hong Kong. Diagnostic Microbiology and Infectious Disease. 76(2). 153–157. 15 indexed citations

19.

Ma, Helen, et al.. (2011). Mindful Paths to Wellbeing and Happiness: Five Programs Compared. Psychotherapy in Australia. 17(2). 64. 3 indexed citations

20.

He, Xijing, Zhu‐Jun Zheng, Ting Song, et al.. (2010). c-Abl regulates estrogen receptor α transcription activity through its stabilization by phosphorylation. Oncogene. 29(15). 2238–2251. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact